spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online April 24, 2009
doi: 10.1242/10.1242/dev.030924

Development 136, 1633-1641 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Pater, E.
Right arrow Articles by Bakkers, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by de Pater, E.
Right arrow Articles by Bakkers, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Distinct phases of cardiomyocyte differentiation regulate growth of the zebrafish heart

Emma de Pater1, Linda Clijsters1, Sara R. Marques2,3, Yi-Fan Lin2, Zayra V. Garavito-Aguilar2, Deborah Yelon2,* and Jeroen Bakkers1,4,*

1 Hubrecht Institute and University Medical Centre Utrecht, 3584 CT, Utrecht, The Netherlands.
2 Kimmel Center for Biology and Medicine, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA.
3 Graduate Program in Areas of Basic and Applied Biology, Universidade do Porto, 4050-465 Porto, Portugal.
4 Interuniversity Cardiology Institute of the Netherlands, 3511 GC, Utrecht, The Netherlands.


Figure 1
View larger version (52K):
[in this window]
[in a new window]

  		Fig. 1. Insufficient proliferation in the myocardium to account for the increase of cardiomyocyte number in the zebrafish heart. (A,C,E) To quantify cardiomyocyte numbers at various stages of development, Tg(cmlc2:dsred2-nuc) embryos of 24, 36 and 48 hpf were fixed, stained using an {alpha}-DsRed antibody and imaged by confocal microscopy. Maximum projections of the DsRed signal is shown in these panels. The dotted line outlines the heart tube; the arterial pole (outflow) is to the top and the venous pole (inflow) to the bottom. Schematics of embryos at the various developmental stages are shown in the left bottom of panels A, C and E; white outlines the embryo and red represents the forming heart tube at each stage. The 24 hpf embryo is shown in dorsal view, the 36 and 48 hpf embryos in anterior view. V, ventricle; A, atrium. (B,D,F) Brightfield images of the embryos shown in A, C and E; dotted lines outline the eyes. (G) Phospho-His staining (brown) on transverse sections through the heart at 36 hpf. The dotted line indicates the myocardium; white arrowhead indicates a phospho-His-positive cell in the neural tube. (H) The total number of phospho-His-positive myocardial cells/embryo at 30 (n=3), 36 (n=3) and 48 hpf (n=6). Bars represent mean±s.e.m. (I,J) BrdU labeling from 24-48 hpf. White arrowheads indicate BrdU-positive (brown) endocardial cells; red arrowhead indicates a BrdU-positive blood cell; black arrow indicates BrdU-positive myocardial cells. (J) Enlargement of the black box in I indicating BrdU-positive cells in the arterial pole of the 48 hpf zebrafish heart; dotted lines outline the myocardium. Scale bars: 50 µm in A,C,E; 25 µm in G; 10 µm in I.

 

Figure 2
View larger version (40K):
[in this window]
[in a new window]

  		Fig. 2. Delayed cardiomyocyte differentiation first arises at the venous pole and later also contributes cells to the arterial pole. (A-I) Developmental timing assay images: reconstruction of confocal z-stacks of eGFP (A,D,G), DsRed (B,E,H), and overlay (C,F,I) from Tg(cmlc2:eGFP)/Tg(cmlc2:dsred2-nuc) embryos. The arterial pole is to the top left; dotted lines outline the eGFP positive heart tubes. Scale bars: 50 µm. (A-C) At 24 hpf, eGFP fluorescence was visible in the entire heart tube. At this time point, no DsRed fluorescence was observed. (D-F) At 36 hpf, the eGFP fluorescence was visible in the entire heart tube. DsRed fluorescence was detected only in the ventricle and at the inner curvature of the atrium. Arrows indicate the regions in the heart tube that are negative for the DsRed signal. (G-I) At 48 hpf, both GFP and DsRed fluorescence were observed in the heart tube. The DsRed signal remained absent from the poles (arrows), which were positive for eGFP. (J,K) Single confocal scan from Tg(cmlc2:GFP)/Tg(cmlc2:dsred2-nuc) embryos at 48 hpf at the level of the arterial pole. Dotted lines indicates the eGFP signal shown in J; arrows in K indicate the most distal outflow tract cells that are positive for eGFP but negative for DsRed. The signal within the heart lumen detected in K but not in J is derived from background fluorescence from red blood cells. Scale bar: 25 µm. (L) Schematic of the location of the eGFPposDsRedpos cells (yellow) and the eGFPposDsRedneg (green) cells in the arterial pole. (M-R) Reconstruction of confocal z-stacks of Tg(cmlc2:Kaede) embryos with the arterial pole of the heart tube to the top. (M-O) Tg(cmlc2:Kaede) embryos photoconverted at 19 hpf and imaged at 26 hpf with the green unconverted signal shown in gray in M, the converted red signal in gray in N and a merged image in O. The arrow indicates the location of atrial cells that are green but not red, indicating that they were not expressing the transgene at the time of photoconversion. The dotted line indicates the green signal at 26 hpf. V, ventricle; A, atrium. (P-R) Tg(cmlc2:Kaede) embryos photoconverted at 34 hpf and imaged at 48 hpf with the green unconverted signal shown in gray in P, the converted red signal in gray in Q and a merged image in R. Images are of a partial reconstruction of confocal z-stacks, allowing a view into the ventricle chamber. The dotted line indicates the green signal at 48 hpf; the arrow in Q indicates the location of distal outflow tract cells that are green but not red, indicating that they were not expressing the transgene at the time of photoconversion.

 

Figure 3
View larger version (42K):
[in this window]
[in a new window]

  		Fig. 3. Isl localization in cardiomyocytes of the future atrium. (A-F) Isl is expressed in cardiac cells located at lateral positions in the cardiac disk. Single z-scans of confocal images of Tg(cmlc2:eGFP) embryos at 23 somites immunofluorescently stained with {alpha}-eGFP and {alpha}-Isl antibodies. C and F show an overlay with eGFP in green and Isl in red. Images in D-F are magnified views of one side of the cardiac disk. Arrows indicate the eGFPposIslpos cells located at lateral positions (future atrium) of the cardiac disk. The white arrowhead indicates Isl-positive cells in the endocardium and the green arrowhead indicates the Isl signal in the trigeminal sensory ganglion. Scale bars: 50 µm.

 

Figure 4
View larger version (41K):
[in this window]
[in a new window]

  		Fig. 4. Cardiac defects of isl1K88X mutant embryos. (A) Cartoon of the Isl1 protein with the location of the premature stop codon (K88X) identified in the isl1 mutant. (B) DNA sequence of a homozygous wild-type sibling (top) and a homozygous isl1K88X mutant (bottom) at the site of the mutation (AAG>TAG) that results in a premature stop codon. (C) The number of heart beats per minute measured at 24, 48 and 72 hpf of wild-type sibling (black squares) and isl1 mutant (white squares) embryos. (D,E) In situ hybridization for bmp4 on 48 hpf wild-type sibling (D) and isl1 mutant (E) embryos. Black arrow (D) indicates bmp4 expression in the sinus venosus of a wild-type embryo; red arrow (E) indicates the inflow area of a representative isl1 mutant embryo lacking bmp4 expression. Embryos are shown as frontal-ventral views (OFT to the top).

 

Figure 5
View larger version (56K):
[in this window]
[in a new window]

  		Fig. 5. Reduced cardiomyocyte differentiation at the venous pole in isl1 mutant embryos. (A-F) Single z-scan of the atrium of a representative isl1K88X sibling (A-C) and mutant (D-F) embryo. White arrow (B) indicates eGFPposDsRedneg cardiomyocytes at the venous pole of the wild-type sibling heart; red arrow (E) indicates the venous pole of the isl1 mutant where only very few eGFPposDsRedneg cells are present. (G,H) Single z-scan of a confocal image at the level of the arterial pole showing the eGFPposDsRedneg cardiomyocytes in the isl1 mutant (white arrow). The region shown is similar to that of the control embryo shown in Fig. 2G-I. V, ventricle: A, atrium. Scale bar: 50 µm. (I) Schematic of the location of the eGFPposDsRedpos cells (yellow) and the eGFPposDsRedneg (green) cells in the arterial pole of the isl1 mutant. (J,K) The number of eGFPposDsRedpos (J) and eGFPposDsRedneg (K) cardiomyocytes per embryo. (K) The eGFPposDsRedneg cardiomyocytes are subdivided into eGFPposDsRedneg cells being present at either the arterial or the venous pole. Note the significant reduction of eGFPposDsRedneg cells at the venous pole in the isl1 mutants. Bars represent mean±s.e.m. **P<0.01.

 

Figure 6
View larger version (47K):
[in this window]
[in a new window]

  		Fig. 6. Fgf signaling is required for the addition of cardiomyocytes to the arterial pole. (A-D) In situ hybridization for sprouty4 (spry4). (A,B) Lateral (A) and dorsal (B) view of a 24 hpf embryo. The arrows indicate the region of spry4 expression near the arterial pole of the heart tube, which could contribute cells to the heart tube. The asterisk indicates the midbrain-hindbrain boundary. In B the heart tube is indicated by the dotted line. (C,D) Dorsal views of 36 hpf embryos that had been treated from 24 hpf until 36 hpf with DMSO (C) or SU5402 (D); spry4 expression in the DMSO-treated embryo is outlined by the dotted line. (E-J) Images of the developmental timing assay (similar to Fig. 2A-I). The arterial pole is at the top left. V, ventricle; A, atrium. The dotted line outlines the eGFP-positive heart tubes. Scale bars: 50 µm. (E-G) A representative fgf8 MO-injected embryo showing reduced heart size. The white arrows indicate the eGFPposDsRedneg cells at the poles of the heart. (H-J) A representative embryo treated with SU5402 from 24-48 hpf. The red arrow indicates the arterial pole, in which eGFPposDsRedneg are absent; the white arrow indicates the eGFPposDsRedneg cells at the venous pole. The peripheral red dots are background signal from yolk granules; the diffuse red signal within the heart tube is due to background fluorescence of red blood cells accumulated within the heart lumen. (K,L) Single z-scan of a confocal image taken from a Tg(cmlc2:eGFP)/Tg(cmlc2:dsred2-nuc) embryo treated with SU5402 from 24-48 hpf. A complete overlap of the eGFP (K) and DsRed (L) signals at the distal tip of the outflow (red arrow) was observed, in contrast to the control embryos represented in Fig. 2J,K. Scale bar: 25 µm. (M) Schematic of the location of the eGFPposDsRedpos cells after SU5402 treatment. (N,O) The number of eGFPposDsRedpos (N) and eGFPposDsRedneg (O) cardiomyocytes/embryo. (O) The eGFPposDsRedneg cardiomyocytes are subdivided into those present at the arterial pole and those present at the venous pole. Bars represent mean±s.e.m. Note the reduction in the number of eGFPposDsRedneg cells located at the arterial pole after fgf8 MO-injection or SU5402 treatment. *P<0.05; **P<0.01.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



© The Company of Biologists Ltd 2009